3,077 results
Search Results
2. Update on 1-benzylpiperazine (BZP) party pills
3. Prenatal exposure to escitalopram and/or stress in rats: A prenatal stress model of maternal depression and its treatment
4. Effect of ABCB1 polymorphisms and atorvastatin on sitagliptin pharmacokinetics in healthy volunteers
5. Assessment of the absorption, metabolism and excretion of [14C]pasireotide in healthy volunteers using accelerator mass spectrometry
6. Dopamine D2/3 occupancy of ziprasidone across a day: a within-subject PET study
7. The effects of liver impairment on the pharmacokinetics of brivanib, a dual inhibitor of fibroblast growth factor receptor and vascular endothelial growth factor receptor tyrosine kinases
8. Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer
9. Pharmacokinetics of colistin in critically ill patients with multidrug-resistant Gram-negative bacilli infection
10. Effects of ketoconazole and esomeprazole on the pharmacokinetics of pazopanib in patients with solid tumors
11. Simultaneous Determination of α- and γ-Mangostins in Mouse Plasma by HPLC–MS/MS Method: Application to a Pharmacokinetic Study of Mangosteen Extract in Mouse
12. Hollow-Fiber-Based LPME as a Reliable Sampling Method for Gas-Chromatographic Determination of Pharmacokinetic Parameters of Valproic Acid in Rat Plasma
13. Bioavailability of intravenous fosphenytoin sodium in healthy Japanese volunteers
14. Pharmacokinetics and metabolism of SL-01, a prodrug of gemcitabine, in rats
15. Influence of Bariatric Surgery on the Use and Pharmacokinetics of Some Major Drug Classes
16. Correlation of contrast agent kinetics between iodinated contrast-enhanced spectral tomosynthesis and gadolinium-enhanced MRI of breast lesions
17. Pharmacokinetics, Tissue Distribution and Excretion of Recombinant Human Parathyroid Hormone 1–84 in Animals
18. Pharmacokinetic disposition of anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in rats and dogs
19. C max and t max verification using Fibonacci sequence and absorption rate
20. Phase I study of oral gemcitabine prodrug (LY2334737) in Japanese patients with advanced solid tumors
21. PLGA 50:50 nanoparticles of paclitaxel: Development, in vitro anti-tumor activity in BT-549 cells and in vivo evaluation
22. HPLC Determination of Gemifloxacin in Different Tissues of Rats Under Normobaric and Hyperbaric Exposure
23. Klinisch relevante pharmakokinetische Arzneimittelinteraktionen in der Intensivmedizin: Eine Übersicht
24. Klinisch relevante pharmakokinetische Arzneimittelinteraktionen in der Intensivmedizin: Eine Übersicht
25. High-performance liquid chromatography with photodiode array detection for determination of nobiletin content in the brain and serum of mice administrated the natural compound
26. Pharmacokinetics and tissue distribution of larotaxel in rats: comparison of larotaxel-loaded microsphere with larotaxel-solution
27. Validated LC-ESI-MS/MS Method for the Quantitation of Neopanaxadiol: a Novel Neuroprotective Agent from Panax ginseng and Its Application to a Pharmacokinetic Study in Rat Plasma
28. Pharmakokinetische Parameter: Altersbedingte Änderungen und Einfluss auf die Therapiefähigkeit
29. A phase I pharmacokinetic study of PM00104 (Zalypsis®) administered as a 24-h intravenous infusion every 3 weeks in patients with advanced solid tumors
30. Simultaneous Quantification of Aliskiren, Valsartan and Sitagliptin by LC with Fluorescence Detection: Evidence of Pharmacokinetic Interaction in Rats
31. Pharmacokinetics of teduglutide in subjects with renal impairment
32. Therapeutic drug monitoring for tomorrow
33. Pharmacokinetics Study of Amoxycillin and Clavulanic acid (8:1)-A New Combination in Healthy Chinese Adult Male Volunteers Using the LC–MS/MS Method
34. Correlations between the selected parameters of the chemical structure of drugs and between-subject variability in area under the curve
35. A mathematical model for the administration of temozolomide: comparative analysis of conventional and metronomic chemotherapy regimens
36. Effect of the P450 oxidoreductase *28 polymorphism on the pharmacokinetics of tacrolimus in Chinese healthy male volunteers
37. Evaluation of chemically diverse 5-HT2C receptor agonists on behaviours motivated by food and nicotine and on side effect profiles
38. Effect of rifampicin on the pharmacokinetics and pharmacodynamics of ticagrelor in healthy subjects
39. CYP2C19 genotype has a major influence on labetalol pharmacokinetics in healthy male Chinese subjects
40. Polymorphisms of UGT1A9 and UGT2B7 influence the pharmacokinetics of mycophenolic acid after a single oral dose in healthy Chinese volunteers
41. A phase I study of tasisulam sodium using an albumin-tailored dose in Japanese patients with advanced solid tumors
42. A phase I study to assess the effect of food on the single dose bioavailability of the THC/CBD oromucosal spray
43. Medikamentöse Therapie bei Frauen – Was gilt es zu beachten?
44. Strategien zur Vermeidung von Antibiotikaresistenzen
45. Pharmacokinetic and tolerability profile of pridopidine in healthy-volunteer poor and extensive CYP2D6 metabolizers, following single and multiple dosing
46. Single ascending oral dose pharmacokinetics and pharmacodynamics study of EV-077: the specific inhibitor of prostanoid- and isoprostane-induced cellular activation
47. Effects of pyridoxine on the intestinal absorption and pharmacokinetics of isoniazid in rats
48. Pharmacokinetic interaction studies of co-administration of ticagrelor and atorvastatin or simvastatin in healthy volunteers
49. Pharmacokinetics of cisplatin during hyperthermic intraperitoneal treatment of peritoneal carcinomatosis
50. Impaired bioavailability and antiplatelet effect of high-dose clopidogrel in patients after cardiopulmonary resuscitation (CPR)
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.